OrganoClick AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 22.26 million compared to SEK 22.64 million a year ago. Net loss was SEK 9.12 million compared to SEK 8.12 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.08 a year ago.
For the nine months, sales was SEK 93.42 million compared to SEK 92.11 million a year ago. Net loss was SEK 23.83 million compared to SEK 20.83 million a year ago. Basic loss per share from continuing operations was SEK 0.24 compared to SEK 0.22 a year ago.